| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |